Cancer Research

How Is AI Transforming In Vivo CAR-T Therapy?
Research & Development How Is AI Transforming In Vivo CAR-T Therapy?

The medical world is standing at the precipice of a pharmaceutical revolution that promises to turn the most sophisticated cancer treatments into accessible, off-the-shelf injections. For years, chimeric antigen receptor T-cell therapy has been a beacon of hope for patients with refractory blood

First Oral Microbiome Nanomedicine Enhances Cancer Immunity
Research & Development First Oral Microbiome Nanomedicine Enhances Cancer Immunity

The persistent challenge of oncological treatment lies not only in identifying malignant cells but also in ensuring that the body’s own immune system remains capable of sustaining a prolonged and effective counterattack. Recent advancements published in the journal Nature Nanotechnology represent a

How Environmental Factors Affect Pediatric Cancer Survivors
Research & Development How Environmental Factors Affect Pediatric Cancer Survivors

The journey of a child who has successfully navigated the grueling path of cancer treatment does not conclude with the ringing of a ceremonial bell; rather, it marks the commencement of a complex, lifelong endeavor to maintain health within an environment that may inadvertently pose significant

KRICT Develops Stable Fluorescent Dye for Cancer Surgery
Research & Development KRICT Develops Stable Fluorescent Dye for Cancer Surgery

Precision in oncology often hinges on the ability to distinguish microscopic malignant cells from healthy tissue, yet current imaging tools frequently fail during the most critical moments of a procedure. While surgeons increasingly rely on near-infrared fluorescence to navigate complex anatomical

Can Creatine Power the Immune System to Fight Cancer?
Research & Development Can Creatine Power the Immune System to Fight Cancer?

The metabolic demands of an immune system engaged in a high-stakes battle against malignant tumors require a consistent and robust energy supply that often exceeds the standard cellular capacity. Within the complex landscape of the tumor microenvironment, cytotoxic T cells frequently find

Can We Predict Immunotherapy Success in Bone Marrow Cancer?
Research & Development Can We Predict Immunotherapy Success in Bone Marrow Cancer?

The medical community has long observed a frustrating paradox in hematological oncology where two patients with nearly identical clinical profiles can have diametrically opposite reactions to the same cutting-edge immunotherapy. While modern medicine has transformed the outlook for various solid

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later